Replies to post #3434 on 1606 Corp (CBDW)

[resx18]

Adnexus Biotechnologies and Sanctum Therapeutics have announced a strategic merger aimed at revolutionizing the way we combat HIV and other infectious diseases. This fusion of cutting-edge artificial intelligence (AI)-driven drug discovery with breakthrough therapeutic innovations marks a pivotal moment in the ongoing battle against some of the world’s most persistent and deadly diseases. CBDW